Extracorporeal Membrane Oxygenation Machine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

LONDON, Nov. 20, 2017 /PRNewswire/ -- The report on the global extracorporeal membrane oxygenation machine (ECMO) market offers a detailed evaluation of various trends and factors impacting the growth of the market over the period of 2017–2022. The research provides in-depth insight into notable clinical developments, technological advances, offerings of key market players, and competitive landscape. The study offers a granular analysis of supply chain and cost structure, prominent pricing strategies, and key factors demand among major regional markets. The study presents a critical insights into the epidemiology of the indications for the use of extracorporeal membrane oxygenation therapies. Furthermore, it provides an evidence-based assessment of regulatory framework impacting the market dynamics in various regions during the assessment period. The market projections during the forecast period helps stakeholders identify current and emerging opportunities, which will enable them to leverage on emerging opportunities in the foreseeable future.



Download the full report: https://www.reportbuyer.com/product/5207202



The global extracorporeal membrane oxygenation machine market is estimated to be worth US$266.3 Mn by 2017 end and is projected to reach a valuation of US$376.0 Mn by 2022 end. The market is forecast to rise at a CAGR of 7.1% during the forecast period (2017–2022).

Global Extracorporeal Membrane Oxygenation Machine Market: Dynamics

The report offers a detailed assessment of key drivers and restraints, regulatory landscape and strategic dynamics prevailing in various regions, and the share and size of various segments. The study offers a comparative analysis by capturing the year-over-year (YoY) growth of various application and modality segments during the historical period (2012–2016) across various regions. The insights are helpful in identifying prominent trends and promising opportunities shaping the growth dynamics of the market.

The extracorporeal membrane oxygenation machine is primarily driven by its rising demand for ECMO therapies for the management of various types of severe cardiac and respiratory failures among adults and children. The growing acceptance of ECMO in managing specific types of acute respiratory distress syndrome (ARDS) is a key factor accentuating the market. The demand for ECMO therapies for providing extracorporeal life support for patients recovering from heart failure or lung failure that do respond to conventional life support modalities such as ventilation bodes well for the market. The growing acceptance of ECMO machines to provide prolonged support for respiratory and cardiac functions in adult patients is opening up exciting opportunities for market players. Furthermore, the soaring popularity of extracorporeal cardiopulmonary resuscitation (ECPR), attributed to its significant survival benefits, in rescuing patients with specific cardiac arrest that does not respond to conventional resuscitation, is expected to open up lucrative avenues during the forecast period.

Global Extracorporeal Membrane Oxygenation Machine Market: Segmentation

The report segments the overall extracorporeal membrane oxygenation machine market on the basis of modality, application, and region.

Based on modality, the report segments the global market broadly into venovenous ECMO, venoarterial ECMO, and arteriovenous ECMO. Of these, the venovenous ECMO segment currently holds the leading share and is anticipated to maintain its lead in the next few years as well.

On the basis of application, the report divides the market into respiratory, cardiology, and extracorporeal cardiopulmonary resuscitation.

The regional markets discussed in the study are Latin America, North America, the Middle East and Africa (MEA), Europe, Asia Pacific excluding Japan (APEJ), and Japan. Of these, the North America extracorporeal membrane oxygenation machine market is anticipated to be the most attractive and is expected to maintain a dominant revenue share throughout the forecast period.

Companies profiled in the report are:

The report offers an elaborate profiling of prominent market players, analyzes factors affecting their revenue share, and highlights key strategies adopted by various companies to gain a better foothold in the market. The market participants can get a critical insight into the strategic landscape and gauge the intensity of the competition during the forecast period. Some of the prominent players profiled in the report are Medtronic Plc., Getinge AB, Terumo Corporation, LivaNova PLC, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, Eurosets S.r.l., and ALung Technologies, Inc.

Download the full report: https://www.reportbuyer.com/product/5207202

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com